Ultragenyx Pharmaceutical | Betriebsaufwand



Operating Expenses Veränderung Datum
Acadia Pharmaceuticals USD 232.19M 7.16M 2025-06
Agios Pharmaceuticals USD 139.51M 24.16M 2025-06
Alnylam Pharmaceuticals USD 789.89M 213.78M 2025-06
BioMarin Pharmaceutical USD 548.52M 27.27M 2025-06
Insmed USD 361.29M 20.33M 2025-06
Ionis Pharmaceuticals USD 312.21M 34.21M 2025-06
Kyowa Hakko Kirin JPY 113.11B 15.82B 2025-06
MacroGenics USD 59M 23.06M 2025-06
Moderna USD 1.04B 113M 2025-06
Neurocrine Biosciences USD 541.9M 7M 2025-06
PTC Therapeutics USD 213.73M 7.86M 2025-06
Regeneron Pharmaceuticals USD 2.6B 159.1M 2025-06
Sarepta Therapeutics USD 495.51M 549.73M 2025-06
Ultragenyx Pharmaceutical USD 274.38M 7.85M 2025-06
Vertex Pharmaceuticals USD 1.81B 71.4M 2025-06


Ultragenyx Pharmaceutical Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2025.